tSCS and AR on Pain and Balance in Diabetic Peripheral Neuropathy
ConditionDiabetic Neuropathies
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRiphah International University
About this trial
tSCS and AR-based training have individually shown benefits in neuromotor rehabilitation; no study to date has evaluated their combined effects on pain, balance, lower-limb strength, retention, and vibration sense in diabetic neuropathy. The rationale for combining them lies in their complementary mechanisms: tSCS at 30 Hz activates large-diameter Aβ afferents, inhibiting nociceptive input, enhancing spinal excitability, and facilitating motor activation.
Eligibility criteria
Qualifiers
More than or equals to 4 score on Douleur Neuropathique 4 Questionnaire
More than or equals to 6 Hz at Neurothesiometer
More than or equals to 4 score on the Numeric Pain Rating Scale (NPRS)
Disqualifiers
Cognitively compromised (MOCA ≤ 26/30)
Metallic implants at skull
Shunting
Skin allergy
Trial design
Treatments tested in this trial
- transcutaneous spinal cord stimulation
- Augmented Reality
Treatment groups
36 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov